420 related articles for article (PubMed ID: 15533905)
1. How strong is the association between CAG and GGN repeat length polymorphisms in the androgen receptor gene and prostate cancer risk?
Zeegers MP; Kiemeney LA; Nieder AM; Ostrer H
Cancer Epidemiol Biomarkers Prev; 2004 Nov; 13(11 Pt 1):1765-71. PubMed ID: 15533905
[TBL] [Abstract][Full Text] [Related]
2. Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: a population-based case-control study in China.
Hsing AW; Gao YT; Wu G; Wang X; Deng J; Chen YL; Sesterhenn IA; Mostofi FK; Benichou J; Chang C
Cancer Res; 2000 Sep; 60(18):5111-6. PubMed ID: 11016637
[TBL] [Abstract][Full Text] [Related]
3. Polymorphic repeats in the androgen receptor gene: molecular markers of prostate cancer risk.
Stanford JL; Just JJ; Gibbs M; Wicklund KG; Neal CL; Blumenstein BA; Ostrander EA
Cancer Res; 1997 Mar; 57(6):1194-8. PubMed ID: 9067292
[TBL] [Abstract][Full Text] [Related]
4. The androgen receptor gene GGN microsatellite and prostate cancer risk.
Platz EA; Giovannucci E; Dahl DM; Krithivas K; Hennekens CH; Brown M; Stampfer MJ; Kantoff PW
Cancer Epidemiol Biomarkers Prev; 1998 May; 7(5):379-84. PubMed ID: 9610786
[TBL] [Abstract][Full Text] [Related]
5. Polymorphic repeats in the androgen receptor gene in high-risk sibships.
Miller EA; Stanford JL; Hsu L; Noonan E; Ostrander EA
Prostate; 2001 Aug; 48(3):200-5. PubMed ID: 11494335
[TBL] [Abstract][Full Text] [Related]
6. Polymorphic CAG/CAA repeat length in the AIB1/SRC-3 gene and prostate cancer risk: a population-based case-control study.
Hsing AW; Chokkalingam AP; Gao YT; Wu G; Wang X; Deng J; Cheng J; Sesterhenn IA; Mostofi FK; Chiang T; Chen YL; Stanczyk FZ; Chang C
Cancer Epidemiol Biomarkers Prev; 2002 Apr; 11(4):337-41. PubMed ID: 11927493
[TBL] [Abstract][Full Text] [Related]
7. Increased risk of breast cancer in women bearing a combination of large CAG and GGN repeats in the exon 1 of the androgen receptor gene.
González A; Javier Dorta F; Rodriguez G; Brito B; Rodríguez MA; Cabrera A; Díaz-Chico JC; Reyes R; Aguirre-Jaime A; Nicolás Díaz-Chico B
Eur J Cancer; 2007 Nov; 43(16):2373-80. PubMed ID: 17728127
[TBL] [Abstract][Full Text] [Related]
8. Androgen receptor polymorphisms and the incidence of prostate cancer.
Chen C; Lamharzi N; Weiss NS; Etzioni R; Dightman DA; Barnett M; DiTommaso D; Goodman G
Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):1033-40. PubMed ID: 12376504
[TBL] [Abstract][Full Text] [Related]
9. Polymorphic CAG and GGC repeat lengths in the androgen receptor gene and prostate cancer risk: analysis of a Brazilian population.
Silva Neto B; Koff WJ; Biolchi V; Brenner C; Biolo KD; Spritzer PM; Brum IS
Cancer Invest; 2008 Feb; 26(1):74-80. PubMed ID: 18181049
[TBL] [Abstract][Full Text] [Related]
10. CAG repeat length in the androgen receptor gene is related to age at diagnosis of prostate cancer and response to endocrine therapy, but not to prostate cancer risk.
Bratt O; Borg A; Kristoffersson U; Lundgren R; Zhang QX; Olsson H
Br J Cancer; 1999 Oct; 81(4):672-6. PubMed ID: 10574254
[TBL] [Abstract][Full Text] [Related]
11. Difference between Swedish and Japanese men in the association between AR CAG repeats and prostate cancer suggesting a susceptibility-modifying locus overlapping the androgen receptor gene.
Li C; Grönberg H; Matsuyama H; Weber G; Nordenskjöld M; Naito K; Bergh A; Bergerheim U; Damber JE; Larsson C; Ekman P
Int J Mol Med; 2003 Apr; 11(4):529-33. PubMed ID: 12632109
[TBL] [Abstract][Full Text] [Related]
12. Is reduced CAG repeat length in androgen receptor gene associated with risk of prostate cancer in Indian population?
Mishra D; Thangaraj K; Mandhani A; Kumar A; Mittal R
Clin Genet; 2005 Jul; 68(1):55-60. PubMed ID: 15952987
[TBL] [Abstract][Full Text] [Related]
13. No association of androgen receptor GGN repeat length polymorphism with infertility in Indian men.
Rajender S; Rajani V; Gupta NJ; Chakravarty B; Singh L; Thangaraj K
J Androl; 2006; 27(6):785-9. PubMed ID: 16809273
[TBL] [Abstract][Full Text] [Related]
14. Androgen receptor CAG polymorphism and prostate cancer risk.
Mononen N; Ikonen T; Autio V; Rökman A; Matikainen MP; Tammela TL; Kallioniemi OP; Koivisto PA; Schleutker J
Hum Genet; 2002 Aug; 111(2):166-71. PubMed ID: 12189490
[TBL] [Abstract][Full Text] [Related]
15. Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era.
Platz EA; Leitzmann MF; Rifai N; Kantoff PW; Chen YC; Stampfer MJ; Willett WC; Giovannucci E
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1262-9. PubMed ID: 15894683
[TBL] [Abstract][Full Text] [Related]
16. The androgen receptor CAG repeat polymorphism and risk of breast cancer in the Nurses' Health Study.
Haiman CA; Brown M; Hankinson SE; Spiegelman D; Colditz GA; Willett WC; Kantoff PW; Hunter DJ
Cancer Res; 2002 Feb; 62(4):1045-9. PubMed ID: 11861380
[TBL] [Abstract][Full Text] [Related]
17. (CAG)nCAA and GGN repeats in the human androgen receptor gene are not associated with prostate cancer in a French-German population.
Correa-Cerro L; Wöhr G; Häussler J; Berthon P; Drelon E; Mangin P; Fournier G; Cussenot O; Kraus P; Just W; Paiss T; Cantú JM; Vogel W
Eur J Hum Genet; 1999 Apr; 7(3):357-62. PubMed ID: 10234512
[TBL] [Abstract][Full Text] [Related]
18. A CAG repeat polymorphism in the androgen receptor gene is associated with reduced bone mass and increased risk of osteoporotic fractures.
Langdahl BL; Stenkjaer L; Carstens M; Tofteng CL; Eriksen EF
Calcif Tissue Int; 2003 Sep; 73(3):237-43. PubMed ID: 14667136
[TBL] [Abstract][Full Text] [Related]
19. Combination of short CAG and GGN repeats in the androgen receptor gene is associated with acne risk in North East China.
Pang Y; He CD; Liu Y; Wang KB; Xiao T; Wang YK; Zhu H; Wei B; Zhao N; Jiang Y; Wei HC; Chen HD
J Eur Acad Dermatol Venereol; 2008 Dec; 22(12):1445-51. PubMed ID: 18624843
[TBL] [Abstract][Full Text] [Related]
20. Allelic variants of aromatase and the androgen and estrogen receptors: toward a multigenic model of prostate cancer risk.
Modugno F; Weissfeld JL; Trump DL; Zmuda JM; Shea P; Cauley JA; Ferrell RE
Clin Cancer Res; 2001 Oct; 7(10):3092-6. PubMed ID: 11595700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
